Meeting Details

The 37th Annual General Meeting (AGM) will be held on Monday, 10th August 2026 at 02.30 p.m. (IST) through Video Conferencing or Other Audio-Visual Means without physical presence of shareholders. This complies with MCA General Circular No 03/2025 dated 22nd September, 2025 and SEBI Circular No. SEBI/HO/DDHS/P/CIR/2023/0164 dated 6th October, 2023.

Agenda Items and Resolutions

Ordinary Business:

1. To receive, consider and adopt the Audited Financial Statements including Balance Sheet, Statement of Profit & Loss and Cash Flow Statement for the year ended 31st March, 2026 along with Reports of Board of Directors and Auditors (Ordinary Resolution).

2. To declare a dividend of ₹1.50 per share (15%) on 1,14,46,290 equity shares of ₹10 each for the year ended 31st March, 2026 (Ordinary Resolution).

3. To appoint a Director in place of Mr. Swapnil Eaga (DIN: 01241535) who retires by rotation and offers himself for re-appointment (Ordinary Resolution).

Special Business:

4. Ratification of remuneration to Cost Auditor for Financial Year 2026-27 (Ordinary Resolution). Shriniwas Diddi & Associates, Cost Accountants, Solapur (Firm Registration No. 100516) appointed at remuneration of ₹55,000 plus GST and reimbursement of out-of-pocket expenses.

5. Appointment/Change in Designation of Ms. Smruthi Eaga (DIN: 09268342) from Non-Executive (Non-Independent) Director to Whole-time Director (Executive) and payment of Remuneration (Special Resolution).

Director Appointment Details (Item 5)

  • Tenure: 3 years from 1st June 2026 to 31st May 2029
  • Remuneration: Salary of ₹7,00,000 per month (₹84,00,000 per annum) plus allowances, benefits and perquisites
  • Annual increment: Not to exceed 15% of relevant remuneration
  • Perquisites: House rent allowance/free accommodation, medical expenses, travel benefits, club memberships, company car with driver, communication facilities
  • Additional benefits: Provident Fund, Gratuity, Leave Encashment as per company rules
  • Commission: May be paid in addition to salary, subject to overall ceiling under Section 197 of Companies Act, 2013
  • Minimum remuneration: Payable even in absence of profits, subject to Central Government approval
  • Termination: 3 months' notice from either side

Financial Performance Context (FY2025-26)

  • Net Sales & Other Income: ₹102.09 crore
  • Total expenses: ₹96.96 crore
  • Profit before exceptional items and tax: ₹5.13 crore
  • Statutory impact of new Labour Codes: ₹0.46 crore
  • Profit before tax: ₹4.66 crore
  • Tax Expense: ₹1.24 crore
  • Profit after Tax: ₹3.43 crore

Shareholder Information

  • Record date: Friday, 31st July 2026 for dividend eligibility
  • Register closure: Saturday, 1st August 2026 to Monday, 10th August 2026 (both days inclusive)
  • Dividend payment: Electronic transfer for shareholders with updated bank details, warrants/cheques for others
  • TDS on dividend: Applicable as per Finance Act, 2020; higher rate of 20% if PAN not registered
  • E-voting period: Friday, 7th August 2026 at 9.00 a.m. to Sunday, 9th August 2026 at 5.00 p.m.
  • Scrutinizer: Mr. H.R. Thakur, Practicing Company Secretary, Mumbai appointed

Director Background

Ms. Smruthi Eaga:

  • Age: 39 years
  • Qualifications: B.Sc from Solapur University, M.S. in Pharmacy from Long Island University, New York
  • Experience: Business development in pharmaceuticals, international marketing, business analysis, regulatory affairs
  • Current remuneration: ₹62.22 lakh per annum for handling international marketing
  • Shareholding: 89,702 shares in the company
  • Relationship: Daughter of Mr. Purushotham Eaga (Chairman and MD), sister of Mr. Swapnil Eaga (Joint MD)

Mr. Swapnil Eaga:

  • Age: 42 years
  • Qualifications: B.S. (Chem) USA & MBA (Finance), Spain
  • Experience: Technical, business development, accounts, costing, MIS & finance
  • Remuneration: ₹120 lakh per annum
  • Shareholding: 600,144 shares
  • Directorships: 1 other company